AI-based differential diagnosis of dementia etiologies on multimodal data
Author:
Xue Chonghua, Kowshik Sahana S., Lteif Diala, Puducheri Shreyas, Jasodanand Varuna H., Zhou Olivia T., Walia Anika S., Guney Osman B., Zhang J. Diana, Pham Serena T., Kaliaev Artem, Andreu-Arasa V. Carlota, Dwyer Brigid C., Farris Chad W.ORCID, Hao Honglin, Kedar SachinORCID, Mian Asim Z., Murman Daniel L., O’Shea Sarah A., Paul Aaron B., Rohatgi Saurabh, Saint-Hilaire Marie-Helene, Sartor Emmett A., Setty Bindu N., Small Juan E.ORCID, Swaminathan Arun, Taraschenko Olga, Yuan Jing, Zhou Yan, Zhu Shuhan, Karjadi Cody, Alvin Ang Ting FangORCID, Bargal Sarah A., Plummer Bryan A., Poston Kathleen L.ORCID, Ahangaran Meysam, Au Rhoda, Kolachalama Vijaya B.ORCID
Abstract
AbstractDifferential diagnosis of dementia remains a challenge in neurology due to symptom overlap across etiologies, yet it is crucial for formulating early, personalized management strategies. Here, we present an AI model that harnesses a broad array of data, including demographics, individual and family medical history, medication use, neuropsychological assessments, functional evaluations, and multimodal neuroimaging, to identify the etiologies contributing to dementia in individuals. The study, drawing on 51, 269 participants across 9 independent, geographically diverse datasets, facilitated the identification of 10 distinct dementia etiologies. It aligns diagnoses with similar management strategies, ensuring robust predictions even with incomplete data. Our model achieved a micro-averaged area under the receiver operating characteristic curve (AUROC) of 0.94 in classifying individuals with normal cognition, mild cognitive impairment and dementia. Also, the micro-averaged AUROC was 0.96 in differentiating the dementia etiologies. Our model demonstrated proficiency in addressing mixed dementia cases, with a mean AUROC of 0.78 for two cooccurring pathologies. In a randomly selected subset of 100 cases, the AUROC of neurologist assessments augmented by our AI model exceeded neurologist-only evaluations by 26.25%. Furthermore, our model predictions aligned with biomarker evidence and its associations with different proteinopathies were substantiated through postmortem findings. Our framework has the potential to be integrated as a screening tool for dementia in various clinical settings and drug trials, with promising implications for person-level management.
Publisher
Cold Spring Harbor Laboratory
Reference83 articles.
1. Organization, W. H. et al. Global Status Report on the Public Health Response to Dementia: Web Annex Methodology for Producing Global Dementia Cost Estimates (World Health Organization, 2022). 2. Who’s global action plan on the public health response to dementia: some challenges and opportunities;Aging & Mental Health,2019 3. Why has therapy development for dementia failed in the last two decades?;Alzheimer’s & Dementia,2016 4. Mixed brain pathologies account for most dementia cases in community-dwelling older persons 5. Disentangling Heterogeneity in Alzheimer’s Disease and Related Dementias Using Data-Driven Methods
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|